Tag "Novo Nordisk"
The price of Novo Nordisk’s star drug drops significantly
Danish Novo Nordisk has announced a drastic price cut in the United States: one of the company’s most popular blood sugar-lowering drugs is now available for $499 per month (approximately...
Read more
Dieting is getting cheaper: price drop in the GLP-1 drug market
In the United States, the price of GLP-1 weight-loss drugs is rapidly decreasing, while more and more users are discovering that the savings from reduced food and beverage purchases almost...
Read more
Novo Nordisk faces slowing growth, new challenges
More subdued investor expectations and market turbulence are overshadowing the growth of Novo Nordisk’s weight loss segment. In the first half of 2025, Novo Nordisk’s sales increased to 154.9 billion...
Read more
Weak US demand and competitive disadvantage weaken Novo Nordisk’s position
Novo Nordisk has revised its 2025 earnings expectations downward for the second time – following the announcement, shares of one of the world’s largest pharmaceutical manufacturers fell by more than...
Read more
Are you losing weight – and your income too? Wegovy’s breakthrough could usher in a new era in the food industry
The success of the Danish Novo Nordisk is gaining worldwide recognition: their anti-obesity drug, Wegovy, is not only considered revolutionary in healthcare, but also generates noticeable effects in the economy....
Read more
In the global market weight class: Novo Nordisk’s dominance in the competition for anti-obesity drugs has been shaken
The weight-loss drug market, which has been booming in the wake of the global obesity epidemic, has taken another turn: Novo Nordisk, which burst into the public consciousness with the...
Read more
Nestlé Launches Website To Support People On Weight-Loss Drugs
Food giant Nestlé’s health unit has launched a web platform to provide nutritional support for individuals on weight loss programmes, including those using GLP-1 medications. Nestlé Health Science said the...
Read more
Everyone wants to lose weight, this is what Europe’s most valuable brand is building on
Denmark’s economy has rarely been in a position to depend on the performance of a single company, Novo Nordisk, but the current situation reflects this. The pharmaceutical giant, whose market...
Read more